Clinical Trial Update: A Study on the Short-course Treatment Regimen Containing Pretomanid for Drug-resistant Tuberculosis [NA]

View source ↗

Summary

Clinical trial update for a short-course pretomanid-containing regimen for drug-resistant tuberculosis, currently not yet recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Drug-resistant Tuberculosis

Drugs mentioned

• Pretomanid (pretomanid)

Snippet

Sponsor: Wuhan Pulmonary Hospital | Conditions: Efficacy and Safety | NA | Status: NOT_YET_RECRUITING